Search Results 551-560 of 19695 for Receptor
A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn ...
... receptor (CAR)-T cell therapy, reported clinical outcomes on the first 274 patients treated with axicabtagene ciloleucel (axi-cel) for relapsed or ...
She has broad training in immunology with specific expertise in T-cell receptor biology, tumor models, antigen presentation and cancer immunotherapy. Dr ...
The benzodiazepine receptor modulator dextofisopam binds to benzodiazepine receptors in the brain, not the GI tract, without a sedating effect. In animal ...
Hefazi directs translational and investigational new drug-enabling research focused on developing chimeric antigen receptor-engineered mesenchymal stem cell ...
An example of an emerging cell therapy is chimeric antigen receptor-T cell therapy (CAR-T cell therapy), which taps the body's biological system to kill cancer.
... receptor 2 (HER2) status by immunohistochemistry (IHC) and in situ hybridization (ISH) scoring. Participating Mayo Clinic locations. Study statuses change ...
Because variations in the cannabinoid receptor 1 (CNR1) gene and the fatty acid amide hydrolase (FAAH) gene are associated with altered gut motility and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.